Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Neuren Pharmaceuticals Limited (NURPF)

Compare
8.60
0.00
(0.00%)
At close: February 28 at 3:00:00 PM EST
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
231,925
231,925
14,553
--
--
Gross Profit
231,925
231,925
14,553
--
--
Operating Expense
32,714
32,714
16,159
11,438
9,532
Operating Income
199,211
199,211
-1,606
-11,438
-9,532
Net Non Operating Interest Income Expense
5,687
5,687
391
41
147
Other Income Expense
225
225
1,389
3,595
186
Pretax Income
205,140
205,140
184
-7,794
-9,193
Tax Provision
48,059
48,059
--
--
--
Net Income Common Stockholders
157,081
157,081
184
-7,794
-9,193
Basic EPS
1.24
1.24
0.00
-0.07
-0.09
Diluted EPS
1.20
1.20
0.00
-0.07
-0.09
Basic Average Shares
127,069.51
127,069.51
125,965.68
117,770.05
107,057.32
Diluted Average Shares
130,791.84
130,791.84
125,965.68
117,770.05
107,057.32
Net Income from Continuing & Discontinued Operation
157,081
157,081
184
-7,794
-9,193
Normalized Income
157,081
157,081
184
-7,794
-9,193
Interest Income
5,687
5,687
391
41
147
Net Interest Income
5,687
5,687
391
41
147
EBIT
199,211
199,211
-1,606
-11,438
-9,532
EBITDA
199,228
199,228
-1,596
-11,430
-9,526
Reconciled Depreciation
17
17
10
8
6
Net Income from Continuing Operation Net Minority Interest
157,081
157,081
184
-7,794
-9,193
Normalized EBITDA
199,228
199,228
-1,596
-11,430
-9,526
Tax Rate for Calcs
0
0
--
--
--
12/31/2020 - 11/4/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VALN Valneva SE
6.75
-5.20%
 
VRDN Viridian Therapeutics, Inc.
15.53
+1.57%
 
CHRO Channel Therapeutics Corporation
2.0500
0.00%
 
NGNE Neurogene Inc.
17.69
+3.45%
 
ASND Ascendis Pharma A/S
156.58
+2.25%
 
MRUS Merus N.V.
47.09
+1.88%
 
KALV KalVista Pharmaceuticals, Inc.
11.40
+6.59%
 
IGC IGC Pharma, Inc.
0.2900
+2.80%
 
TELO Telomir Pharmaceuticals, Inc.
4.0000
+2.30%
 
SCPH scPharmaceuticals Inc.
3.2800
+1.23%